Takuya Miyagawa

15PUBLICATIONS
99CO-AUTHORS
Social epidemiologyNanomedicinePredictive and prognostic markersTumour immunologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 22, 2026
Bimekizumab 2-year efficacy by hidradenitis suppurativa duration: BE HEARD EXT results.

|Jul 07, 2026
Efficacy of Adjuvant Interferon-β Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective Study.

|Mar 03, 2026
Efficacy and safety of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma in Japan: Results of the Japan Clinical Oncology Group single-arm confirmatory trial (JCOG1605).

Kohei Oashi, Dai Ogata, Masayuki Yokoyama

|Feb 13, 2026
Inducible Costimulator and Its Ligand Promote Proliferation and Migration of Tumor Cells in Cutaneous T-Cell Lymphoma.

Kenta Oka, Takuya Miyagawa, Hiromichi Morita

|Jan 05, 2026
Efficacy of adjuvant anti-PD-1 antibody versus observation for resected nail apparatus melanoma.

Takaya Komori, Eiji Nakano, Yukiko Kiniwa

|Oct 22, 2025
Serum Nectin-4 as a Potential Prognostic Biomarker for Extramammary Paget Disease.

Hiromichi Morita, Takuya Miyagawa, Kenta Oka

Pageof 3

Frequent Collaborators

6 joint publications

Kenjiro Namikawa

5 joint publications

Yasuhiro Nakamura

5 joint publications

Dai Ogata

4 joint publications

Shigeto Matsushita